Editorial: Emerging Perspectives on Autoimmune Skin Disorders Driven by Inflammation: Current Trends and Challenges
By
Manoj Kumar Tembhre
Alpana Sharma
Pankaj Dipankar
Shanid Mohiyuddin
Mohammad Tarique
Suneel Kumar
July 7, 2026
Clinical Scorecard: Emerging Perspectives on Autoimmune Skin Disorders Driven by Inflammation: Current Trends and Challenges
At a Glance
Category Detail
Condition Autoimmune Skin Disorders Key Mechanisms Deregulation of immune cell interactions and keratinocyte functions leading to inflammatory skin conditions. Target Population Individuals with autoimmune skin disorders such as vitiligo, psoriasis, and systemic sclerosis. Care Setting Dermatology and immunology clinics.
Key Highlights
Keratinocytes play a crucial role in immune responses and skin inflammation. Emerging immunotherapies target specific pathways and immune cells in skin disorders. JAK inhibitors have been FDA approved for vitiligo treatment. Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of psoriasis. Selective targeting of IL-23 p19 subunit shows promise in psoriasis treatment. Guideline-Based Recommendations
Diagnosis
Identify autoimmune skin disorders through clinical evaluation and histopathological examination. Management
Utilize targeted immunotherapies such as JAK inhibitors and B-cell depletion therapies. Monitoring & Follow-up
Regularly assess disease activity and treatment response in patients. Risks
Consider potential adverse effects of immunotherapies and monitor for infections. Patient & Prescribing Data
Patients with autoimmune skin disorders requiring advanced treatment options.
Next-generation immunotherapies are shifting the focus from generalized immunosuppression to targeted approaches.
Clinical Best Practices
Incorporate multi-omics techniques to identify therapeutic targets. Evaluate the role of immune biomarkers in guiding treatment strategies. Monitor neutrophil activity and NET formation in inflammatory skin conditions. Related Resources & Content
